Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats

{{article.zuoZheEn}}

PDF(5130 KB)
PDF(5130 KB)
Front. Med. ›› 2019, Vol. 13 ›› Issue (3) : 398-408. DOI: 10.1007/s11684-019-0689-5
RESEARCH ARTICLE

Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2019, 13(3): 398‒408 https://doi.org/10.1007/s11684-019-0689-5

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(5130 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉